Logo
Login

Company Executives

$ Management Team

Ms. Anna Protopapas

Non-Executive Independent Chairman of the Board

Age 60
Compensation $481.9K USD
Sex Female

Dr. James Porter

President

Chief Executive Officer

Director

Age 49
Compensation $17.28M USD
Sex Male

Ms. Alexandra Balcom

Chief Financial Officer

Treasurer

Age 41
Compensation $5.487M USD
Sex Female

Dr. Henry Pelish

Chief Scientific Officer

Age 52
Compensation -
Sex Male

Ms. Darlene Noci

Chief Development Officer

Age 48
Compensation $5.450M USD
Sex Female

Dr. Christopher Turner

Chief Medical Officer

Age 57
Compensation $5.551M USD
Sex Male

Dr. Deborah Miller

Chief Legal Officer

Secretary

Age 49
Compensation $5.462M USD
Sex Female

Board of Directors

From the proxy statement filed Apr 28, 2026
Directors
9
serving now
Independent
0 of 1
stated in the proxy; 8 not stated
Average tenure
4.0 years
from year joined
CEO also chairs the board
No
Anna Protopapas
Director Age On board Independent Committees Other public boards 2025 pay Source
Michael L. Meyers
76 2022
4 years
 Not stated
nominating and corporate governance committee · Chair
None stated Not stated
Ron Squarer
59 2025
1 year
 Not stated None stated ADC Therapeutics SA, Travere Therapeutics, Inc. $602,452
Christy Oliger
56 2025
1 year
 Not stated
audit committee
Vera Therapeutics, Inc., Karyopharm Therapeutics Inc., Replimune Group Inc. $627,666
Sapna Srivastava
55 2021
5 years
 Not stated
audit committee · Chair
Aura Biosciences, Inc., Alumis Inc. Not stated
Cameron A. Wheeler
47 2017
9 years
 Not stated
compensation committee
None stated Not stated
Grant C. Bogle
68 2024
2 years
 Not stated
compensation committee · Chair
None stated $449,927
James R. Porter
CEO
 50 2020
6 years
 Not independent None stated None stated Paid as CEO
Anna Protopapas
Board chair
 61 2022
4 years
 Not stated None stated None stated $485,432
Joseph Pearlberg Leaving at the meeting
Not stated Not stated Not stated None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans